上海瑞齐生物科技有限公司作者
Rabbit Anti-ID1
资料类型 | jpg文件 | 资料大小 | 4730 |
下载次数 | 34 | 资料图片 | 【点击查看】 |
上 传 人 | 上海瑞齐生物科技有限公司 | 需要积分 | 0 |
关 键 词 | Rabbit Anti-ID1Rabbit Anti-ID1,Rabbit Anti-ID1,Ant |
- 【资料简介】
- Rabbit Anti-ID1Catalog Number :RS-3529RQuantity size : 0.1/0.2ml (dilute with pH 7.4 0.01 M PBS or antibody diluent )Background: VID proteins contain a helix-loop-helix (HLH) motif and regulate tissue-specific transcription within several cell lineages. They do not bind DNA directly, but inhibit lineage commitment by binding basic helix-loop-helix (bHLH) transcription factors through their HLH motif. ID proteins contribute to cell growth, senescence, differentiation and angiogenesis. Id1 mRNA is highly expressed in heart, lung and kidney and has lower expression in brain and liver. Two transcript variants encoding different isoforms have been found for this gene.pecificity :– Anti- ID1 is a rabbit monoclonal antibody unconjugated– specific for ID1 of human ,rat– use for western blotting,elisa,immunoprecipitation and immunohistochemistry– Protein G affinity chromatography purification, purity :>95%– Isotype: IgG– mol wt: 16kDaRabbit Anti-ID1Application :– Western blotting 1:100-500– Immunohistochemistry 1:100-500– ELISA 1:500-1000– Optimal working dilutions must be determined by the end user.Storage: Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody, the antibody is stable for at least six weeks at 2-4 ℃Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Rabbit Anti-ID1
- 凡本网注明"来源:环保在线"的所有作品,版权均属于环保在线,转载请必须注明环保在线,https://www.hbzhan.com。违反者本网将追究相关法律责任。
- 企业发布的公司新闻、技术文章、资料下载等内容,如涉及侵权、违规遭投诉的,一律由发布企业自行承担责任,本网有权删除内容并追溯责任。
- 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
- 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。